Share-Based Compensation (Tables) - Stock Options [Member]

9 Months Ended

12 Months Ended

Sep. 30, 2020

Dec. 31, 2019

Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]

Schedule of equity plan to purchase the Company's common stock

During 2017, the Company granted the following options outside of any equity plan with the attributes described below to purchase the Company's common stock (amounts in US$'s, except share data):

Grant Date	Underlying Shares		Option Price		Full Vesting Date	Expiration Date
January 9, 2017		100,000	$	2.90	January 9, 2019	January 7, 2021
August 3, 2017		5,130,000	$	0.50	August 3, 2017	August 3, 2021
November 9, 2017		2,000,000	$	0.50	November 9, 2017	November 9, 2021
December 13, 2017		200,000	$	1.00	November 13, 2019	December 13, 2021

During 2018, the Company granted the following options outside of any equity plan with the attributes described below to purchase the Company's common stock (amounts in US$'s, except share data):

Grant Date	Underlying Shares		Vesting	Option Price		Full Vesting Date	Expiration Date
March 28, 2018		100,000	50% in one year; 50% in two years from grant date	$	1.00	March 28, 2020	March 28, 2022
May 16, 2018		330,000	Immediate vesting	$	1.00	May 16, 2018	May 16, 2022
May 16, 2018		130,000	50% in one year; 50% in two years from grant date	$	1.00	May 16, 2020	May 16, 2022
September 26, 2018		6,000,000	$4,000,000 new government orders	$	0.65	December 21, 2018	September 26, 2022

Schedule of assumptions used to estimate fair value stock options granted

	2020
Expected dividend yield		0	%
Expected volatility		38.17	%
Risk-free interest rate		0.205 - 0.310	%
Expected life of options		3.25 - 5.00 years

	2019
Expected dividend yield		0%
Expected volatility		90%
Risk-free interest rate		2.40-2.47%
Expected life of options		4.0 years

Schedule of stock option activity

	Number of Options			Weighted- Average Exercise Price per Share		Weighted- Average Contractual Life in Years		Aggregate Intrinsic Value
Outstanding – December 31, 2019		8,695,000		$	0.63		1.34	$	2,264,760
Exercisable – December 31, 2019		8,695,000			0.63		1.34		2,264,760
Granted		2,725,506			0.26
Exercised		—			—
Cancelled or Expired		(1,100,000	)		0.67
Outstanding – September 30, 2020		10,320,506		$	0.53		2.26	$	19,338,950
Exercisable – September 30, 2020		10,220,506		$	0.53		2.24	$	19,206,950

	Number of Options			Weighted- Average Exercise Price per Share		Weighted- Average Contractual Life in Years		Aggregate Intrinsic Value
Outstanding – January 10, 2019		13,990,000		$	0.61		3.15	$	—
Exercisable – January 10, 2019		13,610,000			0.59		2.42		—
Granted		180,000			1.06
Exercised		—			—
Cancelled or Expired		(50,000	)		0.90
Outstanding – September 30, 2019		14,120,000		$	0.61		1.68	$	3,796,960
Exercisable – September 30, 2019		13,745,000		$	0.60		1.67	$	3,796,960

	Number of Options			Weighted- Average Exercise Price per Share		Weighted- Average Contractual Life in Years		Aggregate Intrinsic Value
Outstanding – January 10, 2019		13,990,000		$	0.61		3.15	$	—
Granted		180,000			1.06
Exercised		(5,250,000	)		0.57
Cancelled or Expired		(225,000	)		0.72
Outstanding – December 31, 2019		8,695,000		$	0.63		1.34	$	2,264,760
Exercisable – December 31, 2019		8,695,000		$	0.63		1.34	$	2,264,760